Effects of Lumacaftor/Ivacaftor on Cystic Fibrosis Disease Progression in Children 2 through 5 Years of Age Homozygous for F508del-CFTR: A Phase 2 Placebo-controlled Clinical Trial. - Stahl M; Roehmel J; Eichinger M; Doellinger F; Naehrlich L; Kopp MV; Dittrich AM; Lee C; Sommerburg O; Tian S; Xu T; Wu P; et al. (Annals of the American Thoracic Society, 2023)